Tuhura Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.81

-0.14 (-7.18%)

As of Mar 29, 10:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +668.5% upside

Low Target $12.64

Average Target $13.91

High Target $18.47

Current Price $1.81

Current
$1.81

Target
$13.91

$12.64 $13.91 avg $18.47

Scenario Analysis

Bear Case

$12.64

598.3%

Low target

Base Case

$13.91

+668.5%

Avg target

Bull Case

$18.47

+920.4%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$4.44

-59.2% from high

52-Week Low

$0.41

+341.5% from low

Target vs 52W High

$13.91

+213.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%